An internationally - recognized head and
neck cancer researcher and faculty leader with a proven track record in promoting diversity was named today as the new executive vice dean for academic affairs for the U-M Medical School.
Not exact matches
Researchers at Oregon State University are pursuing a new concept in treatment of epithelial
cancer, especially head and
neck cancer, by using two promising «analogs» of an old compound that was once studied as a potent anti-tumor agent, but long ago abandoned because it was too toxic.
In back - to - back papers published online July 28 in Science,
researchers from the Broad Institute, Dana - Farber
Cancer Institute, Johns Hopkins Kimmel Cancer Center, the University of Pittsburgh, and the University of Texas MD Anderson Cancer Center have confirmed genetic abnormalities previously suspected in head and neck cancer, including defects in the tumor suppressor gene known a
Cancer Institute, Johns Hopkins Kimmel
Cancer Center, the University of Pittsburgh, and the University of Texas MD Anderson Cancer Center have confirmed genetic abnormalities previously suspected in head and neck cancer, including defects in the tumor suppressor gene known a
Cancer Center, the University of Pittsburgh, and the University of Texas MD Anderson
Cancer Center have confirmed genetic abnormalities previously suspected in head and neck cancer, including defects in the tumor suppressor gene known a
Cancer Center have confirmed genetic abnormalities previously suspected in head and
neck cancer, including defects in the tumor suppressor gene known a
cancer, including defects in the tumor suppressor gene known as p53.
Another collaboration was unfolding among the
cancer geneticists, sequencing experts, clinical
researchers, and surgical oncologists at Johns Hopkins, MD Anderson, and Baylor College of Medicine to study 32 pairs of head and
neck tumor and normal tissue samples by whole - exome sequencing and validate the findings in an additional 88 samples.
Since then, however, other
researchers have observed the same gene fusion in a percentage of lung, esophageal, breast, head and
neck, cervical, and bladder
cancers, affecting tens of thousands of
cancer patients overall.
The
researchers treated 76 patients between 1993 and 1996 with intensive therapy for advanced
cancers of the head and
neck.
Intensive treatment combining radiation and chemotherapy can control locally advanced head and
neck cancer, improve survival, and in most cases eliminate the need for debilitating surgery, report
researchers from the University of Chicago Medical Center and Northwestern University in the April 14, 2000, issue of the Journal of Clinical Oncology.
During the study, the
researchers tracked the pre-and-post treatment diets and ultimate health outcomes of more than 400
cancer patients for an average of 26 months after they were first diagnosed and treated for squamous - cell carcinoma of the head or
neck.
Researchers from the University of Illinois at Urbana - Champaign have found that consuming higher amounts of carbohydrates and various forms of sugar a year prior to treatment for head or
neck cancer could increase risk of
cancer recurrence and mortality.
In 2007,
researchers at St. Louis University School of Medicine found that people who spend a lot of time behind the wheel tend to develop more skin
cancers on the left side of their heads,
necks, and arms — the side nearest the drivers window.
Cats tend to have a type of skin
cancer in their heads and mouths that some
researchers are using as a model for human head and
neck cancers.